SMH Specialist Among Leading Physician Researchers Issuing Latest Guidance for Thyroid Cancer Care

SMH Specialist Among Leading Physician Researchers Issuing Latest Guidance for Thyroid Cancer Care

Sarasota Memorial thyroid/parathyroid specialist Ralph P. Tufano, MD, MBA, FACS, has been recognized among a panel of leading medical experts who have issued new guidelines for the treatment of differentiated thyroid cancer (DTC), the most prevalent cancer of the thyroid.

Friday, September 5, 2025
Sarasota Memorial’s Kolschowsky Research and Education Institute Joins Clinical Trial for Patients with Hard-to-Treat Ovarian Cancer

Sarasota Memorial’s Kolschowsky Research and Education Institute Joins Clinical Trial for Patients with Hard-to-Treat Ovarian Cancer

Women with advanced or recurring ovarian, peritoneal, or fallopian tube cancer may be eligible to participate in a new clinical trial offered by Sarasota Memorial’s Kolschowsky Research and Education Institute.

Tuesday, August 26, 2025
Donors, Doctors, Staff Inscribe Messages of Hope, Healing for Future Patients of SMH’s New Cancer Pavilion

Donors, Doctors, Staff Inscribe Messages of Hope, Healing for Future Patients of SMH’s New Cancer Pavilion

Dozens of donors, doctors, staff and leaders of Sarasota Memorial Health Care System’s Brian D. Jellison Cancer Institute left their mark Friday on SMH’s newest cancer facility – the Milman-Kover Cancer Pavilion. The new outpatient facility is slated to open early next year on SMH's Sarasota campus.

Monday, June 16, 2025
SMH Cancer Specialists Using AI-Driven, 3D Imaging to Improve Surgical Outcomes for Cancer Patients

SMH Cancer Specialists Using AI-Driven, 3D Imaging to Improve Surgical Outcomes for Cancer Patients

Surgeons with Sarasota Memorial’s Brian D. Jellison Cancer Institute are using AI-powered, 3D surgical imaging to enhance precision and improve outcomes for cancer patients

Thursday, May 15, 2025
Sarasota Memorial Joins Multi-Center Trial of New Drug Targeting Resistant, Late-Stage Ovarian Cancer

Sarasota Memorial Joins Multi-Center Trial of New Drug Targeting Resistant, Late-Stage Ovarian Cancer

In an effort to improve treatment outcomes, Sarasota Memorial’s Brian D. Jellison Cancer Institute and research team are part of a clinical trial investigating a novel therapy formulated to overcome the resistance to treatment that can build up in late-stage ovarian cancer patients. 

Wednesday, April 2, 2025
RSS
123456